Although synovitis is the pathological hallmark of rheumatoid arthritis (RA), many extra-
articular manifestations (EMs) and comorbidities likely occur due to the complex, chronic …

Patients with rheumatoid arthritis (RA) and other inflammatory joint diseases (IJDs) have an
increased risk of premature death compared with the general population, mainly because of …

Objectives: To develop evidence-based EULAR recommendations for cardiovascular (CV)
risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and …

There is intense interest in mechanisms whereby low-grade inflammation could interact with
conventional and novel vascular risk factors to promote the atheromatous lesion. Patients …

Objective—C-reactive protein (CRP) levels predict outcome in healthy individuals and
patients with atherosclerosis. Arterial stiffness also independently predicts all-cause and …

Background—Rheumatoid arthritis (RA) is associated with increased cardiovascular risk,
which is not explained by traditional cardiovascular risk factors but may be due in part to …

RA associates with an increased burden of cardiovascular disease, which is at least partially
attributed to classical risk factors such as hypertension (HT) and dyslipidaemia. HT is highly …

Objective To determine the outcome of pregnancy in women with rheumatoid arthritis (RA) in
relation to disease activity and medication use during the pregnancy. Methods In a …

Chronic inflammatory diseases are associated with premature atherosclerosis; however, it is
unknown whether arterial stiffness is increased in this setting, possibly as a manifestation of …

RA is characterized by a systemic inflammatory state, in which immune cells and soluble
mediators play a crucial role. These inflammatory processes resemble those in other chronic …